BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22333708)

  • 1. Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients.
    Myklebust MP; Fluge Ø; Immervoll H; Skarstein A; Balteskard L; Bruland O; Dahl O
    Br J Cancer; 2012 Feb; 106(4):756-62. PubMed ID: 22333708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal.
    Wong CS; Tsao MS; Sharma V; Chapman WB; Pintilie M; Cummings BJ
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):309-14. PubMed ID: 10487550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinated expression of desmoglein 1 and desmocollin 1 regulates intercellular adhesion.
    Getsios S; Amargo EV; Dusek RL; Ishii K; Sheu L; Godsel LM; Green KJ
    Differentiation; 2004 Oct; 72(8):419-33. PubMed ID: 15606501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C.
    Cummings BJ; Keane TJ; O'Sullivan B; Wong CS; Catton CN
    Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1115-25. PubMed ID: 1938508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology Group.
    Bonin SR; Pajak TF; Russell AH; Coia LR; Paris KJ; Flam MS; Sauter ER
    Cancer; 1999 Mar; 85(6):1226-33. PubMed ID: 10189126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assembly of desmosomal cadherins into desmosomes is isoform dependent.
    Ishii K; Norvell SM; Bannon LJ; Amargo EV; Pascoe LT; Green KJ
    J Invest Dermatol; 2001 Jul; 117(1):26-35. PubMed ID: 11442746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
    Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
    Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined radiation and chemotherapy for epidermoid carcinoma of the anal canal.
    Schneider IH; Grabenbauer GG; Reck T; Köckerling F; Sauer R; Gall FP
    Int J Colorectal Dis; 1992 Dec; 7(4):192-6. PubMed ID: 1293239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
    Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
    Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
    Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281).
    Meropol NJ; Niedzwiecki D; Shank B; Colacchio TA; Ellerton J; Valone F; Budinger S; Day JM; Hopkins J; Tepper J; Goldberg RM; Mayer RJ
    J Clin Oncol; 2008 Jul; 26(19):3229-34. PubMed ID: 18490648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
    Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor expression as prognostic marker in patients with anal carcinoma treated with concurrent chemoradiation therapy.
    Fraunholz I; Rödel F; Kohler D; Diallo-Georgiopoulou M; Distel L; Falk S; Rödel C
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):901-7. PubMed ID: 23755922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.
    Lancet; 1996 Oct; 348(9034):1049-54. PubMed ID: 8874455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outcome of simultaneous radiochemotherapy of anal carcinoma].
    Fraunholz IB; Adamietz IA; Lorenz M; Staib-Sebler E; Böttcher HD
    Zentralbl Chir; 1997; 122(1):39-43. PubMed ID: 9133135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definitive chemoradiotherapy for anal canal cancer: single-center experience.
    Tachibana I; Nishimura Y; Inada M; Fukuda K; Ishikawa K; Nishikawa T; Yokokawa M; Nakamatsu K; Kanamori S; Hida JI
    Int J Clin Oncol; 2018 Dec; 23(6):1121-1126. PubMed ID: 29992389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal.
    Bazan JG; Hara W; Hsu A; Kunz PA; Ford J; Fisher GA; Welton ML; Shelton A; Kapp DS; Koong AC; Goodman KA; Chang DT
    Cancer; 2011 Aug; 117(15):3342-51. PubMed ID: 21287530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of colostomy free survival in patients presenting with locally advanced anal canal carcinoma: A pooled analysis of two prospective trials (KANAL 2 and ACCORD 03).
    Faivre JC; Peiffert D; Vendrely V; Lemanski C; Hannoun-Levi JM; Mirabel X; Stanbury T; Salleron J; Guillemin F
    Radiother Oncol; 2018 Dec; 129(3):463-470. PubMed ID: 30172453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy.
    Graf R; Wust P; Hildebrandt B; Gögler H; Ullrich R; Herrmann R; Riess H; Felix R
    Oncology; 2003; 65(1):14-22. PubMed ID: 12837978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.